γδ T cells are effectors of immunotherapy in cancers with HLA class I defectsN. de Vries, Emile E. Voest|Nature|2023Cited by 290
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast CancerSjoerd Rodenhuis, Elisabeth G.E. de Vries, L.V.A.M. Beex et al.|New England Journal of Medicine|2003Cited by 262